74 related articles for article (PubMed ID: 10931219)
1. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver.
Shimonishi T; Miyazaki K; Nakanuma Y
Histopathology; 2000 Jul; 37(1):55-63. PubMed ID: 10931219
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
[TBL] [Abstract][Full Text] [Related]
3. Liver metastases of colorectal adenocarcinoma with intrahepatic biliary spread pattern: clinical manifestation and importance of immunohistochemical analysis.
Díaz Vico T; Castellón Pavón CJ; Díaz García GA; Torres Alemán A; Pérez Domene MT; Sánchez Infante S; Fuel Gómez DC; Durán Poveda M
Clin J Gastroenterol; 2023 Oct; 16(5):693-697. PubMed ID: 37306864
[TBL] [Abstract][Full Text] [Related]
4. Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma.
Tayao M; Andrici J; Farzin M; Clarkson A; Sioson L; Watson N; Chua TC; Sztynda T; Samra JS; Gill AJ
PLoS One; 2016; 11(3):e0150338. PubMed ID: 26982343
[TBL] [Abstract][Full Text] [Related]
5. Histological and immunohistochemical features of carcinomas with pulmonary involvement in cattle.
Vielmo A; Santos IR; Piva MM; Bandinelli MB; Pavarini SP; Panziera W; Driemeier D
Vet Pathol; 2024 Mar; 61(2):179-189. PubMed ID: 37638494
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms.
Gonzalez-Mancera MS; Siref A; Kosari K; Nissen N; Gaddam S; Hendifar A; Osipov A; Waters K; Hutchings D; Guindi M; Larson BK
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38345293
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic mucinous cholangiocarcinoma with recurrent colic in a horse: case report and literature review of cholangiocarcinoma in horses.
Barrantes Murillo DF; Cattley RC; Cullen JM; Withers C; Towns J; Pfeifle R; Wooldridge A; Neto RLALT
J Vet Diagn Invest; 2024 Apr; ():10406387241245775. PubMed ID: 38641993
[TBL] [Abstract][Full Text] [Related]
8. The Analysis of Human Epidermal Growth Receptor-2 (HER-2) in Gastric Cancer in a Tertiary Hospital in Sub-Saharan Africa.
Duduyemi BM; Asante E; Asiamah E; Afihene MY
Niger Med J; 2021; 62(4):178-182. PubMed ID: 38694214
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma mimicking a liver abscess.
Yacoub H; Hassine H; Boukriba S; Haouet S; Ayari A; Kchir H; Maamouri N
Clin Case Rep; 2020 Dec; 8(12):2510-2513. PubMed ID: 33363768
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic panniculitis as the initial presentation of intrahepatic cholangiocarcinoma.
Montes de Oca MK; Jamison RA
JAAD Case Rep; 2018 Jul; 4(6):528-530. PubMed ID: 30023419
[No Abstract] [Full Text] [Related]
11. About cytokeratin 19 and the drivers of liver regeneration.
Junge N; Sharma AD; Ott M
J Hepatol; 2017 Oct; ():. PubMed ID: 29031907
[No Abstract] [Full Text] [Related]
12. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Lok T; Chen L; Lin F; Wang HL
Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
Kalekou H; Miliaras D
Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
[TBL] [Abstract][Full Text] [Related]
15. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Jain R; Fischer S; Serra S; Chetty R
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):9-15. PubMed ID: 19956064
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
Hughes NR; Bhathal PS
J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
[TBL] [Abstract][Full Text] [Related]
17. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
Werling RW; Yaziji H; Bacchi CE; Gown AM
Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin expression profile in gastric carcinomas.
Kim MA; Lee HS; Yang HK; Kim WH
Hum Pathol; 2004 May; 35(5):576-81. PubMed ID: 15138932
[TBL] [Abstract][Full Text] [Related]
19. A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review.
Iliesiu A; Toma RV; Ciongariu AM; Costea R; Zarnescu N; Bîlteanu L
Oncol Lett; 2023 Oct; 26(4):442. PubMed ID: 37720666
[TBL] [Abstract][Full Text] [Related]
20. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
